Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT07064538
NA
Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits
Sponsor: Mackay Memorial Hospital
View on ClinicalTrials.gov
Summary
To evaluate the efficacy of Neuralli® MP in improving participant-defined outcomes in adults with autistic traits.
Official title: A Mixed-Methods Open-Label Trial Evaluating the Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2025-08-19
Completion Date
2026-08-31
Last Updated
2025-08-24
Healthy Volunteers
No
Conditions
Interventions
DIETARY_SUPPLEMENT
Neuralli® MP
Neuralli® MP containing 60 billion CFU (administered as two capsules per day)
Locations (1)
Mackay Memorial Hospital
Taipei, Taiwan